Xcovery Drug Patent Portfolio
Xcovery owns 1 orange book drug protected by 4 US patents Given below is the list of Xcovery's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10899744 | Crystalline form of compound suppressing protein kinase activity, and application thereof | 01 Jun, 2037 | Active |
| US9126947 | Substituted pyridazine carboxamide compounds | 29 Nov, 2031 | Active |
| US9296724 | Substituted pyridazinecarboxamides as kinase inhibitors | 18 Jun, 2029 | Active |
| US8551995 | Kinase inhibitor compounds | 09 Feb, 2029 | Active |
Latest Legal Activities on Xcovery's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Xcovery.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Yr, Small Entity | 08 Apr, 2025 | US8551995 |
| Initial letter Re: PTE Application to regulating agency | 20 Feb, 2025 | US9126947 |
| Patent Term Extension Application under 35 USC 156 Filed | 13 Feb, 2025 | US9126947 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 24 Jul, 2024 | US10899744 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 29 Sep, 2023 | US9296724 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 08 Mar, 2023 | US9126947 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 08 Apr, 2021 | US8551995 |
| Recordation of Patent Grant Mailed | 26 Jan, 2021 | US10899744 |
| Patent Issue Date Used in PTA Calculation | 26 Jan, 2021 | US10899744 |
| Email Notification | 07 Jan, 2021 | US10899744 |
| Issue Notification Mailed | 06 Jan, 2021 | US10899744 |
| Dispatch to FDC | 21 Dec, 2020 | US10899744 |
| Email Notification | 20 Nov, 2020 | US10899744 |
| Mail Examiner Interview Summary (PTOL - 413) | 20 Nov, 2020 | US10899744 |
| Interview Summary Record | 18 Nov, 2020 | US10899744 |
Xcovery's Family Patents
Xcovery Drug List
Given below is the complete list of Xcovery's drugs and the patents protecting them.
1. Ensacove
Ensacove is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10899744 | Crystalline form of compound suppressing protein kinase activity, and application thereof |
01 Jun, 2037
(11 years from now)
| Active |
| US9126947 | Substituted pyridazine carboxamide compounds |
29 Nov, 2031
(5 years from now)
| Active |
| US9296724 | Substituted pyridazinecarboxamides as kinase inhibitors |
18 Jun, 2029
(3 years from now)
| Active |
| US8551995 | Kinase inhibitor compounds |
09 Feb, 2029
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ensacove's drug page